+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Neurovascular Intervention Devices Market Research Report by Product, Process, Disease Pathology, Therapeutic Applications, Application, End-use, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 143 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5722762
The United States Neurovascular Intervention Devices Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Neurovascular Intervention Devices Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Neurovascular Intervention Devices Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Neurovascular Intervention Devices Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Neurovascular Intervention Devices Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Neurovascular Intervention Devices Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Neurovascular Intervention Devices Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market is studied across Balloon Systems, Carotid Stents, Catheters, Embolic Coils, Embolic Protection Devices, Flow Diverters, Guidewires, Intracranial Stents, Intrasaccular Devices, Neurothrombectomy Devices, and Stent Retrievers.
  • Based on Process, the market is studied across Carotid Endarterectomy, Cerebral Angiography, Coiling, Flow Diversion, Microsurgical Clipping, Neurothrombectomy, and Stenting.
  • Based on Disease Pathology, the market is studied across Arteriovenous Malformations & Fistulas, Carotid Artery Stenosis, Cerebral Aneuryms, and Ischemic Strokes.
  • Based on Therapeutic Applications, the market is studied across Brain Aneurysm, Ischemic Strokes, and Stenosis.
  • Based on Application, the market is studied across Arteriovenous Malformation, Intracranial Aneurysm, and Ischemic Stroke.
  • Based on End-use, the market is studied across Ambulatory Surgical Centers and Hospitals.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Neurovascular Intervention Devices Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Neurovascular Intervention Devices Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Neurovascular Intervention Devices Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Neurovascular Intervention Devices Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Neurovascular Intervention Devices Market, including Abbott Laboratories, Acandis GmbH, Boston Scientific Corporation, Evasc Medical Systems Corp., Johnson & Johnson Services, Inc., LivaNova PLC, Medikit Co., Ltd., Medtronic PLC, Microport Scientific Corporation, Penumbra, Inc., Phenox GmbH, Rapid Medical Ltd., Stryker Corporation, and Terumo Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Neurovascular Intervention Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Neurovascular Intervention Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Neurovascular Intervention Devices Market?
4. What is the competitive strategic window for opportunities in the United States Neurovascular Intervention Devices Market?
5. What are the technology trends and regulatory frameworks in the United States Neurovascular Intervention Devices Market?
6. What is the market share of the leading vendors in the United States Neurovascular Intervention Devices Market?
7. What modes and strategic moves are considered suitable for entering the United States Neurovascular Intervention Devices Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalance of neurovascular disorders
5.1.1.2. Rising government support and favorable reimbursement scenario
5.1.2. Restraints
5.1.2.1. Stringent and time-consuming approval process
5.1.3. Opportunities
5.1.3.1. Technological advancements in neurovascular intervention devices
5.1.4. Challenges
5.1.4.1. Dearth of technical expertise
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Neurovascular Intervention Devices Market, by Product
6.1. Introduction
6.2. Balloon Systems
6.3. Carotid Stents
6.4. Catheters
6.5. Embolic Coils
6.6. Embolic Protection Devices
6.7. Flow Diverters
6.8. Guidewires
6.9. Intracranial Stents
6.10. Intrasaccular Devices
6.11. Neurothrombectomy Devices
6.12. Stent Retrievers

7. Neurovascular Intervention Devices Market, by Process
7.1. Introduction
7.2. Carotid Endarterectomy
7.3. Cerebral Angiography
7.4. Coiling
7.5. Flow Diversion
7.6. Microsurgical Clipping
7.7. Neurothrombectomy
7.8. Stenting

8. Neurovascular Intervention Devices Market, by Disease Pathology
8.1. Introduction
8.2. Arteriovenous Malformations & Fistulas
8.3. Carotid Artery Stenosis
8.4. Cerebral Aneuryms
8.5. Ischemic Strokes

9. Neurovascular Intervention Devices Market, by Therapeutic Applications
9.1. Introduction
9.2. Brain Aneurysm
9.3. Ischemic Strokes
9.4. Stenosis

10. Neurovascular Intervention Devices Market, by Application
10.1. Introduction
10.2. Arteriovenous Malformation
10.3. Intracranial Aneurysm
10.4. Ischemic Stroke

11. Neurovascular Intervention Devices Market, by End-use
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals

12. California Neurovascular Intervention Devices Market
12.1. Introduction

13. Florida Neurovascular Intervention Devices Market
13.1. Introduction

14. Illinois Neurovascular Intervention Devices Market
14.1. Introduction

15. New York Neurovascular Intervention Devices Market
15.1. Introduction

16. Ohio Neurovascular Intervention Devices Market
16.1. Introduction

17. Pennsylvania Neurovascular Intervention Devices Market
17.1. Introduction

18. Texas Neurovascular Intervention Devices Market
18.1. Introduction

19. Competitive Landscape
19.1. FPNV Positioning Matrix
19.1.1. Quadrants
19.1.2. Business Strategy
19.1.3. Product Satisfaction
19.2. Market Ranking Analysis, By Key Player
19.3. Market Share Analysis, By Key Player
19.4. Product Portfolio Analysis, By Key Player
19.5. Competitive Scenario
19.5.1. Merger & Acquisition
19.5.2. Agreement, Collaboration, & Partnership
19.5.3. New Product Launch & Enhancement
19.5.4. Investment & Funding
19.5.5. Award, Recognition, & Expansion

20. Company Usability Profiles
20.1. Abbott Laboratories
20.2. Acandis GmbH
20.3. Boston Scientific Corporation
20.4. Evasc Medical Systems Corp.
20.5. Johnson & Johnson Services, Inc.
20.6. LivaNova PLC
20.7. Medikit Co., Ltd.
20.8. Medtronic PLC
20.9. Microport Scientific Corporation
20.10. Penumbra, Inc.
20.11. Phenox GmbH
20.12. Rapid Medical Ltd.
20.13. Stryker Corporation
20.14. Terumo Corporation

21. Appendix
21.1. Discussion Guide
21.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET DYNAMICS
FIGURE 8. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 12. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2022 VS 2030 (%)
FIGURE 24. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY PROCESS, 2030
FIGURE 26. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, 2018-2030 (USD MILLION)
FIGURE 31. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2022 VS 2030 (%)
FIGURE 34. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 35. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY DISEASE PATHOLOGY, 2030
FIGURE 36. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS & FISTULAS, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ARTERY STENOSIS, 2018-2030 (USD MILLION)
FIGURE 38. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYMS, 2018-2030 (USD MILLION)
FIGURE 39. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, 2018-2030 (USD MILLION)
FIGURE 40. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2022 VS 2030 (%)
FIGURE 41. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 42. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY THERAPEUTIC APPLICATIONS, 2030
FIGURE 43. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BRAIN ANEURYSM, 2018-2030 (USD MILLION)
FIGURE 44. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, 2018-2030 (USD MILLION)
FIGURE 45. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS, 2018-2030 (USD MILLION)
FIGURE 46. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 47. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 48. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 49. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2030 (USD MILLION)
FIGURE 50. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2030 (USD MILLION)
FIGURE 51. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2030 (USD MILLION)
FIGURE 52. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 53. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 54. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USE, 2030
FIGURE 55. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
FIGURE 56. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 57. CALIFORNIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. FLORIDA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. ILLINOIS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. NEW YORK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. OHIO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. PENNSYLVANIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. TEXAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 65. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 66. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY STATE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY STATE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS & FISTULAS, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS & FISTULAS, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ARTERY STENOSIS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ARTERY STENOSIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYMS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYMS, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BRAIN ANEURYSM, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BRAIN ANEURYSM, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY STATE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. CALIFORNIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 72. CALIFORNIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. CALIFORNIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 74. CALIFORNIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 75. CALIFORNIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 76. CALIFORNIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. CALIFORNIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. FLORIDA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 79. FLORIDA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. FLORIDA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 81. FLORIDA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 82. FLORIDA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 83. FLORIDA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. FLORIDA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. ILLINOIS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 86. ILLINOIS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. ILLINOIS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 88. ILLINOIS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 89. ILLINOIS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 90. ILLINOIS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. ILLINOIS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. NEW YORK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 93. NEW YORK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. NEW YORK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 95. NEW YORK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 96. NEW YORK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 97. NEW YORK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. NEW YORK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. OHIO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 100. OHIO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. OHIO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 102. OHIO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 103. OHIO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 104. OHIO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. OHIO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 106. PENNSYLVANIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 107. PENNSYLVANIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. PENNSYLVANIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 109. PENNSYLVANIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 110. PENNSYLVANIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 111. PENNSYLVANIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. PENNSYLVANIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 113. TEXAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 114. TEXAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. TEXAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 116. TEXAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 117. TEXAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 118. TEXAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. TEXAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 121. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 122. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 123. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET RANKING, BY KEY PLAYER, 2022
TABLE 124. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 125. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 126. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET MERGER & ACQUISITION
TABLE 127. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 128. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 129. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET INVESTMENT & FUNDING
TABLE 130. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 131. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Acandis GmbH
  • Boston Scientific Corporation
  • Evasc Medical Systems Corp.
  • Johnson & Johnson Services, Inc.
  • LivaNova PLC
  • Medikit Co., Ltd.
  • Medtronic PLC
  • Microport Scientific Corporation
  • Penumbra, Inc.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Stryker Corporation
  • Terumo Corporation

Methodology

Loading
LOADING...